Cargando…
Acute Migraine Therapy: New Drugs and New Approaches
The conceptual shift of our understanding of migraine from a vascular disorder to a brain disorder has dramatically altered the approach to the development of new medicines in the field. Current pharmacologic treatments of acute migraine consist of nonspecific and relatively specific agents. Migrain...
Autores principales: | Monteith, Teshamae S., Goadsby, Peter J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016076/ https://www.ncbi.nlm.nih.gov/pubmed/21110235 http://dx.doi.org/10.1007/s11940-010-0105-6 |
Ejemplares similares
-
Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021) -
Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022) -
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021) -
Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022) -
Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)